Walleye Trading LLC Celldex Therapeutics, Inc. Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $129,984 - $233,696	5,749 Added 69.02%	14,079 $558,000
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $5,293 - $7,791	-208 Reduced 2.44%	8,330 $229,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $258,616 - $326,834	8,538 New	8,538 $289,000
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $405,310 - $662,094	-14,590 Reduced 87.14%	2,153 $95,000
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $86,986 - $143,968	3,832 Added 29.68%	16,743 $471,000
Q2 2022 Aug 08, 2022	BUY	$20.5 - $37.33 $107,092 - $195,011	5,224 Added 67.96%	12,911 $348,000
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $212,468 - $302,252	7,687 New	7,687 $262,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $125,522 - $197,957	-3,518 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $101,846 - $196,972	3,518 New	3,518 $190,000
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $55,140 - $86,795	-5,714 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $9,199 - $76,624	5,714 New	5,714 $74,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.